Introduction
Accurate determination of cardiac output (Qc) is important in the hemodynamic evaluation of valve area, pulmonary and systemic vascular resistance, and severity of heart failure. The Fick method [cardiac output (Q c ) = oxygen uptake (V O 2 ) / systemic arterio-venous oxygen difference] 1, 2 is the time-honored gold standard for determining Qc, and has been used to validate other techniques such as indicator dilution and foreign gas rebreathing 3 . Application of the Fick method requires measurement of V O 2 . However, direct measurement of V O 2 through (a) mass spectrometry analysis of timed Douglas bag collections of exhaled air; or (b) breath-by-breath analysis of exhaled air using indirect calorimetry or metabolic cart analysis 4, 5 is time consuming and involves specific equipment that requires frequent calibration and is expensive to maintain.
As a result, resting V O 2 is commonly estimated rather than measured using derived formulae available in the peer-reviewed literature [6] [7] [8] [9] . However, the accuracy of the formulae and nomograms most commonly used to estimate resting V O 2 is questionable, with most estimating methods derived from limited samples of highly selected, ethnically homogenous populations consisting of similarly aged, lean adults, [10] [11] [12] populations that differ substantially from contemporary adult cardiology practice. Other formulae were derived from clinical populations comprised exclusively or primarily of infants and children 6, 8 . Hence, we assessed the accuracy of estimated resting V O 2 compared with measured V O 2 obtained by the gold-standard analysis of timed collections of exhaled air by the method of Douglas in a large population of consecutive adult patients who underwent right-heart cardiac catheterization for clinical indications at our hospital.
analysis of exhaled air using indirect calorimetry or metabolic cart analysis , 5 is ti time me me c con onsu sumi ming and involves specific equipment that requires frequent calibration and is expensiv ive e e to to to m m mai ai aint nt ntai ai ain n n.
As a a r r res es esul ul ult, t, t, r r res e e ti ing ng ng V V O 2 is commonly estimated r r rat at athe h r than measured d us us usin in i g derived formulae av av vai i ila l ble in n t th he he p p pee eer-r--r re revi vi view ew ewed ed d l l lit it iter er erat at atur ur u e e 6-9 6-9 9 . Ho Ho H we we ev ve er, t t the he he a a acc cc cur ur rac a a y y y of of of t t the he h for or rmu mu mula la lae e e an an nd d d 
Calculating estimated V O 2
Estimated resting V O 2 was calculated by the formula of Dehmer, et al. 7, 9 : V O 2 (ml/min) = 125
(ml/min/m 2 ) x body surface area (BSA, m 2 ), with BSA calculated according to the formula of 
Direct measurement of V O 2
Resting V O 2 was measured in all patients using the gold-standard technique of Douglas 1 , with analysis of a three-minute collection of exhaled air collected through a properly fitted mouth piece with a three-way valve. Exhaled volume was measured with a Tissot spirometer and concentrations of oxygen, carbon dioxide and nitrogen were determined by mass spectrometry (Marquette MGA 1100), calibrated prior to every measurement, and all testing was completed while patients remained in the supine position.
Statistical analysis
ml/min/m 2 ) x body surface area (BSA, m 2 ), with BSA calculated according to th th he e e fo fo form rm rmul ul ula a a of of of The magnitude of agreement between directly measured and estimated resting V O 2 was assessed by median absolute difference, ordinary least products regression 14 and typical error analysis 15 .
Median absolute difference (ml/min) for the overall cohort was calculated as a median of the absolute value of the differences between measured and estimated resting V O 2 determined for each patient. The degree of disagreement between measured and estimated resting V O 2 was calculated as a percent error, dividing the absolute difference by the corresponding measured oxygen uptake, and multiplying by 100. Ordinary least products regression was used to assess both fixed and proportional error for the overall cohort 14 . Variance of comparative plot data points for estimated vs. measured V O 2 in the overall cohort was assessed by intra-class correlation coefficient. Typical error estimation, expressed as a coefficient of variation derived from the standard deviation of the mean absolute difference divided by the square root of 2 15 , is reported for BMI (body mass index) strata. Median absolute difference between measured and estimated resting V O 2 was assessed in the overall cohort and in patients stratified by (a) BMI using clinical categories (<25, 25-29.9; 30-34.9; 35-39.9; 40 kg/m 2 ); (b) sex; and (c) age stratified by median split. The one-sample Wilcoxon signed-ranks test was used to determine statistical significance for the median of the raw difference of values between estimated and measured V O 2 in the overall cohort and in patients stratified by sex, age, and BMI categories.
Tests for interaction were used to assess statistical significance for median absolute difference Attempts to develop a more accurate estimating equation using the present data included piecewise linear models, restricted cubic splines, additive models, variable transformations, including interaction terms and higher-order variables. Cross-validated samples were obtained in 100 iterations, with 75% used as the training set and 25% used as the validation set. All testing was 2-tailed at a significance level of 0.05, with analyses performed using SAS Version 9.1.3
(Cary, NC, USA) and no corrections made for multiple comparisons.
Results
Patient characteristics for the overall cohort and selected strata are shown in Table 1 . The overall cohort comprised 535 patients, with mean age 55 years, 53% were women, and the mean BMI was 28.4 kg/m 2 . The mean measured V O 2 for the overall cohort was 241 ± 56.6 ml/min (mean ± standard deviation; Re Re esu su ul lt lts s P Pa P ti i ient character r ris st tics s fo o or th the e o over r l al all l c coh h hort an n nd s sel le ect ted ed ed s s st tr tra at ta a a are e sho ow wn n in in n T Ta Tabl The magnitude of error between measured and estimated V O 2 expressed as a percent error for the overall cohort is shown in Figure 2 . For all three formulae used to estimate V O 2 , the degree of error ranged from 10 to 25% in approximately 40% of the overall cohort, and the error was >25% in 17-25% of the cohort, depending on the estimating formula used.
The median absolute difference between measured and estimated V O 2 using the three formulae was stratified by BMI, sex, and age, as shown in Table 2 . When estimating V O 2 using the Dehmer formula, the difference in measured and estimated V O 2 widened as BMI increased, with significant disagreement between measured and estimated V O 2 observed in all BMI strata.
Patients with BMI <40 kg/m 2 had a median absolute difference ranging from 24.6 (11.6, 43. Table 2 ).
Both measured and estimated V O 2 were higher in men compared with women ( Table 2) .
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In analyses stratified by median age, median absolute difference between estimated and measured V O 2 comparisons for age groups 55 years and >55 years were both large [31.7 (13.5, 55.2) ml/min and 26.5 (12.7, 46.6) ml/min, respectively, p<0.0001 for each] when calculated by the Dehmer formula, though the differences between the two groups did not reach statistical significance (p=0.13). In assessment of both LaFarge and Bergstra formulae, the median absolute difference for both age strata were >30 ml/min, and the differences between age groups similarly did not reach statistical significance ( Table 2 ; p=0.92 and p=0.20; respectively).
We were unable to resolve or improve upon the discordance between measured and estimated resting V O 2 using data-derived estimating equations, which we explored using a variety of methods of multivariable linear regression. In all cases of the exploratory models, the mean bias was unacceptably large, and the median percent difference was no less than 15%.
Additionally, the predicted R 2 based on the PRESS statistic 17 yielded values no larger than 0.27 (data not shown), demonstrating unacceptably poor model performance.
To demonstrate the clinical importance of error in resting V O 2 estimation, we calculated hypothetical Fick-derived Q c based on resting and estimated V O 2 from all three formulae for each patient in the study. Fick-derived Q c values were used to derive hypothetical aortic valve areas (AVA) by the Hakki equation 18 , as a clinical example to determine the effect of errors in resting V O 2 estimation For this analysis, each patient was assigned an hypothetical mean aortic ignificance (p=0.13). In assessment of both LaFarge and Bergstra formulae, the m m med ed edia ian n ab abso sol lute difference for both age strata were >30 ml/min, and the differences between age gr gr rou ou oups ps s s s sim im imil il ilar ar arly ly y did not reach statistical significance ( Table 2 ; p=0.92 and p=0.20; respe p ctively).
We w w wer ere e un un u ab able le e t to o o re re r so solv lv lve e e or or i imp mpro rove ve up u on on Table 3 ). The LaFarge formula had similar sensitivity, specificity and AUC when compared to the Dehmer formula; the Bergstra formula had the lowest sensitivity of 75% (95% CI 71-79%) of the formulae tested, but was significantly more specific (77%; 95% CI 68-86%) with a slightly greater AUC of 0.82 (95% CI 0.77-0.87) when compared with the other formulae (Figure 3) . Similarly, the optimal ROC cutpoint for the Bergstra formula (0.94 cm 2 ) was the closest of the three formulae to the clinically important diagnostic cutoff of 1.0 cm 2 ( Table 3 
Discussion
This study demonstrates that in a large, consecutive sample of adult patients undergoing rightheart cardiac catheterization, estimation of resting V O 2 by commonly used formulae is inaccurate compared with the gold-standard analysis of timed collections of exhaled air. We previously demonstrated the inaccuracy of resting V O 2 estimation in a smaller cohort of research participants 25 . The present observations confirm and extend these prior findings of exaggerated error in the most obese patients, now in a larger sample of adult patients in a clinical o derive the Bergstra formula 8 were infants and children with congenital heart d d dis isea e e se se e, , po po poss ss ssib ibly y confounding the application of these methods in adult patients. Prior studies have demonstrated er rro ro rors rs rs i in n V V O O O 2 2 est sti im imation using g these and other fo form rm rmulae in pediat t tri ri r c 19-9--22 22 22 and adult [23] [24] [25] po o p p pu pulations. h Howe wever, t these e a analyses ha have l lim mitat tio ons i inc nclu lud ding g s small sa ampl ple size e w with h homo moge gene neit ity of f p pat atie ient nt p pop o ul lat atio ion n, lack k of of s sub ub-g gro roup up a ana naly lysi sis s in n d de ete term rmin ining g ot othe her va ari riab able les s th that may influenc nce e er erro rors rs i in n e esti tima mati ion on, an and d us use e fe fewe wer r an anal a yt ytic ic m met etho hods s t to o ex expl plai ain n th the e er erro rors setting where such methods are commonly applied. Several of the contemporary formulae for estimating V O 2 6, 8 incorporate weight or body surface area without taking into account the degree of adiposity, which may impact the accuracy of estimation, since fat has little impact on oxygen consumption. In addition, there is a metabolic requirement for accommodating excess weight, including physical support and respiratory efforts, all of which may materially influence resting V O 2 . While predictive formulae for maximal V O 2 have adjusted for the metabolic cost associated with excess adiposity to improve accuracy 26, 27 , whether similar adiposity adjustments for the estimation of V O 2 at rest could improve accuracy remains to be determined.
In contrast to our previous study where estimation with mean absolute difference was exaggerated in men compared with women, we found no significant difference in observed disagreement between measured and estimated V O 2 at rest when stratified by sex in the present study. We postulate that results from our previous study may be explained by the fact that on average, men have greater absolute and proportional fat-free mass than women, which likely contributed to the sex-based error of the estimating formula. In the present analyses, the error was numerically greater in men compared with women using the Dehmer and Bergstra formulae, whereas with the LaFarge formula the error was numerically greater in women. However, the magnitude of differences was not statistically significant between the groups, and none of the formulae yielded a significant statistical interaction between error and sex, challenging the necessity of inclusion of sex as is done in the LaFarge and Bergstra formulae.
Although early nomograms for estimating V O 2 at rest, some of which were derived from pediatric populations, were stratified by age 10, 11 , we found no age-based error association in this study. No association between the degree of error of the estimating formula and age was present
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The errors encountered when resting V O 2 is estimated instead of directly measured can potentially impact clinical decision making, including determining the initiation and titration of inotropic support, decision for mechanical ventricular support, determining eligibility and monitoring response of pulmonary vasodilator therapy, and determining candidacy for valve procedures, among others.
Clinical Implications
The Committee convened to discuss the potential role of using pulmonary vascular resistance index (PVRI) and its change in response to therapy as a surrogate for drug efficacy in pediatric patients with pulmonary arterial hypertension (PAH). Therapy in these pediatric patients would consist of drugs with approved indications in adults 28 . In this context, in both pediatric and adult PAH patients, virtually all of the available data from clinical trials had been compiled using estimating formulae for resting V O 2 , a key parameter in the calculation of PVRI 29 . Given the degree of error of the estimation of resting V O 2 in the present study, and the absence of validation or critical assessment in the pediatric population, the routine use of resting V O 2 estimation in the calculation of hemodynamics and their response to therapy for drug registration studies should be closely scrutinized, if not abandoned.
Limitations
Our study has limitations. Differences in methods between operators with regard to exhaled air collection and analysis could have influenced the accuracy of resting V O 2 measurement using the method of Douglas. However, to address this, a specific protocol was followed by all operators and the equipment was routinely maintained and calibrated. In addition, while patients were stationary and in a steady state condition prior to timed collections of exhaled air, it is unlikely that this method equates to a true resting V O 2 measurement given the anxiety associated with cardiac catheterization and the variable clinical stability across a population of patients undergoing right heart catheterization for clinical purposes.
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Conclusions
Errors in hemodynamic assessment may adversely impact clinical assessment and therapeutic decision-making across a spectrum of serious cardiovascular conditions. Given the imperative in such situations for accuracy of assessment, if the Fick method is to be used for Qc estimation, resting V O 2 should be directly measured and not estimated.
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